TrialJAMA network open2022

Efficacy and Safety of Vamorolone in Duchenne Muscular Dystrophy: A 30-Month Nonrandomized Controlled Open-Label Extension Trial.

Jean K Mah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.